Dr. Masrur received his medical degree in 2006 from the University of Cuyo in Mendoza, Argentina and completed his residency in General Surgery at the Italian Hospital of Mendoza. His journey at the University of Illinois started in 2010 when he became a research specialist in the field of Minimally Invasive and Robotic Surgery. He then completed a 2 years clinical fellowship in Minimally Invasive, Bariatric and Robotic Surgery with the Division of General Surgery. He had an early involvement in Robotic Surgery and actively participated in the Basic training of Robotics of physicians from different specialties as part of the proctoring team at UIC. Currently, Dr. Masrur is an assistant professor of surgery at the UIC medical center.
Dr. Masrur published several scientific papers, as well book chapters, in the field of Robotic and Bariatric Surgery.
Surgical interests: Minimally Invasive Bariatric, Foregut and HPB surgery
Languages spoken: English, Spanish
Important LAP-BAND® System Safety Information
Indications: The LAP-BAND® System is indicated for weight reduction for patients with obesity, with a Body Mass Index (BMI) of at least 40 kg/m2 or a BMI of at least 30 kg/m2with one or more obesity-related co-morbid conditions. It is indicated for use only in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.
Contraindications: The LAP-BAND® System is not recommended for non-adult patients, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.
Warnings: The LAP-BAND® System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.
Adverse Events: Placement of the LAP-BAND® System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the esophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.
Important: For full safety information please click here, talk with your doctor, or call Apollo Customer Support at 1-855-551-3123
CAUTION: Rx only.